Tesamorelin / TESA

growth hormone-releasing factor analog is a stabilized synthetic analog of growth hormone–releasing hormone (GHRH) developed as a molecular tool for investigating hypothalamic–pituitary–somatotropic axis regulation. Structurally derived from the endogenous GHRH sequence with targeted amino-acid modifications that enhance resistance to enzymatic degradation, growth hormone-releasing factor analog has been widely used in endocrine and metabolic research to explore mechanisms governing pulsatile growth hormone (GH) secretion and downstream insulin-like growth factor-1 (IGF-1) signaling pathways.

In receptor-level studies, growth hormone-releasing factor analog acts as an agonist at the GHRH receptor (GHRH-R) expressed on anterior pituitary somatotroph cells, triggering cyclic AMP–mediated signaling cascades that promote GH synthesis and release. Laboratory investigations frequently utilize growth hormone-releasing factor analog to evaluate feedback dynamics between hypothalamic peptides, pituitary hormone output, and peripheral metabolic responses. Its improved pharmacokinetic stability relative to native GHRH allows researchers to examine sustained stimulation paradigms, pulsatility modeling, and receptor desensitization processes under controlled experimental conditions.

Within cellular and animal research models, growth hormone-releasing factor analog has been applied to studies of lipid metabolism, adipocyte signaling, hepatic IGF-1 production, and interactions between GH axis activity and inflammatory mediators. The compound is also used in mechanistic experiments assessing somatotropic effects on body-composition pathways, mitochondrial function, and endocrine cross-talk involving insulin sensitivity and nutrient partitioning. Analytical approaches such as ELISA-based hormone quantification, transcriptomic profiling, and metabolic flux assays commonly incorporate growth hormone-releasing factor analog as a controlled upstream stimulus of GH pathway activation.

Each vial from Flowptides contains research-grade growth hormone-releasing factor analog with verified identity and purity. This material is supplied solely for in vitro and ex vivo laboratory research applications and is not intended for human consumption, clinical investigation, or therapeutic use of any kind.

NOT included – BAC Water !! (all products are research use only).

FDA DISCLAIMER

The information provided on this website has not been evaluated by the U.S. Food and Drug Administration (FDA). None of the statements herein, nor any of the products offered, are intended to diagnose, treat, cure, or prevent any medical condition.

All products are supplied strictly as laboratory research reagents and are not for human consumption. We do not provide products to patients and do not make any claims regarding medical use.

Flowptides Peptides operates solely as a chemical supplier. It is not a compounding pharmacy and does not operate as a compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act.